Explore 3 Stock Ideas & Industry Insights Download Free Report
Neurocrine Biosciences (NASDAQ:NBIX) First Quarter 2025 Results Key Financial Results Revenue: US$572.6m (up 11% from 1Q 2024). Net income: US$7.90m (down 82% from 1Q 2024). Profit margin: 1.4% (down from 8.4% in 1Q 2024). EPS: US$0.079 (down from US$0.43 in 1Q 2024). AI is …
CNA Financial (NYSE:CNA) First Quarter 2025 Results Key Financial Results Revenue: US$3.63b (up 5.3% from 1Q 2024). Net income: US$274.0m (down 19% from 1Q 2024). Profit margin: 7.6% (down from 9.8% in 1Q 2024). The decrease in margin was driven by higher expenses. EPS: …
V2X (NYSE:VVX) First Quarter 2025 Results Key Financial Results Revenue: US$1.02b (flat on 1Q 2024). Net income: US$8.11m (up by US$6.96m from 1Q 2024). Profit margin: 0.8% (up from 0.1% in 1Q 2024). EPS: US$0.26 (up from US$0.036 in 1Q 2024). We've found 21 …
Air Lease (NYSE:AL) First Quarter 2025 Results Key Financial Results Revenue: US$738.3m (up 11% from 1Q 2024). Net income: US$364.8m (up 274% from 1Q 2024). Profit margin: 49% (up from 15% in 1Q 2024). EPS: US$3.27 (up from US$0.88 in 1Q 2024). We've discovered …
Here are five stocks added to the Zacks Rank #1 (Strong Buy) List today: Safran SA SAFRY: This aerospace and defense company has seen the Zacks Consensus Estimate for its current year earnings increasing 5.5% over the last 60 days. Safran SA Price and …
Q2 sales increased 1% and organic sales increased 7%* Q2 GAAP EPS of $0.71; Q2 Adjusted EPS* of $0.82 Q2 orders increased 5% organically year-over-year Building Solutions backlog of $14.0 billion increased 12% organically year-over-year Initiates fiscal Q3 and raises full year fiscal 2025 …
The latest on trade talks, Real ID requirements for travel, pharma stocks tumble, and more news to start your day. Continue Reading View Comments
Record first quarter annualized recurring revenue, reflecting ongoing execution of the Connect & Scale strategy Maintaining full year 2025 guidance WESTMINSTER, Colo., May 7, 2025 /PRNewswire/ -- Trimble Inc. (Nasdaq: TRMB) today announced financial results for the first quarter of 2025. First Quarter 2025 …
Shareholders in Recursion Pharmaceuticals, Inc. (NASDAQ:RXRX) had a terrible week, as shares crashed 27% to US$4.16 in the week since its latest first-quarter results. It wasn't the greatest result, with ongoing losses and revenues of US$15m falling short of analyst predictions. The losses were …
CALGARY, AB, May 7, 2025 /CNW/ - Canadian Utilities Limited (TSX: CU)CU Q1 2025 (CNW Group/Canadian Utilities Limited) Canadian Utilities Limited (Canadian Utilities or the Company) today announced first quarter 2025 adjusted earnings (1) of $232 million ($0.85 per share), which were $7 million …
Please wait processing your request...
You are not subscribed for this report, Want to See?
One of our sales representative will contact you soon!
Welcome to Kalkine!
Start Your 7-Days Free Trial Today!
Hi! How can we help you today?
Loading…